Drug recalls
Every medicine recall reported to the FDA since 2012, newest first. Last checked for new ones 1 day ago.
18,166 recalls
- Class III Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, Indi… Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit. Alembic Pharmaceuticals Limited · Nov 26, 2025 · Ongoing
- Class II Acetaminophen 500mg Caffeine 65mg caplets, packaged as 2 caplets per packet further packaged in a 50-count box, AERO TAB, Manufactured for AERO HEALTHCARE US, V… Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. Aero Healthcare · Nov 12, 2025 · Ongoing
- Class II clomiPRAMINE Hydrochloride, Capsules, USP, 75 mg, packaged in a) 30-count bottles (NDC 16714-851-01), b) 90-count bottles (NDC 16714-851-02), c) 100 capsules, N… cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acc… Zydus Pharmaceuticals (USA) Inc · Nov 12, 2025 · Ongoing
- Class II clomiPRAMINE Hydrochloride, Capsules, USP, 50 mg, packaged in a) 30-count bottles (NDC 16714-850-01), b) 90-count bottles (NDC 16714-850-02), c) 100-count bottl… cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acc… Zydus Pharmaceuticals (USA) Inc · Nov 12, 2025 · Ongoing
- Class II clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC 16714-849-02), c) 100-count bottl… cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acc… Zydus Pharmaceuticals (USA) Inc · Nov 12, 2025 · Ongoing
- Class II Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Can… Subpotent drug; Clavulanate Potassium component Teva Pharmaceuticals USA, Inc · Nov 12, 2025 · Ongoing
- Class II Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pha… Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 6… Sun Pharmaceutical Industries Inc · Nov 5, 2025 · Ongoing
- Class II Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pha… Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 6… Sun Pharmaceutical Industries Inc · Nov 5, 2025 · Ongoing
- Class II Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pha… Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 6… Sun Pharmaceutical Industries Inc · Nov 5, 2025 · Ongoing
- Class II Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pha… Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 6… Sun Pharmaceutical Industries Inc · Nov 5, 2025 · Ongoing
- Class II Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pha… Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 6… Sun Pharmaceutical Industries Inc · Nov 5, 2025 · Ongoing
- Class II Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pha… Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 6… Sun Pharmaceutical Industries Inc · Nov 5, 2025 · Ongoing
- Class II Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pha… Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 6… Sun Pharmaceutical Industries Inc · Nov 5, 2025 · Ongoing
- Class II 0.9% SODIUM CHLORIDE Injection, USP, 100 mL, Rx only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC 0990-7984-37 Lack of Assurance of Sterility: Potential for flexible container leaks. Otsuka ICU Medical LLC · Nov 5, 2025 · Ongoing
- Class III Everolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge,… Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. Endo USA, Inc. · Nov 5, 2025 · Ongoing
- Class III Everolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, N… Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. Endo USA, Inc. · Nov 5, 2025 · Ongoing
- Class III Everolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, N… Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. Endo USA, Inc. · Nov 5, 2025 · Ongoing
- Class III Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY… Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C. Endo USA, Inc. · Nov 5, 2025 · Ongoing
- Class III Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604 Labeling: Not Elsewhere Classified Letco Medical LLC · Nov 5, 2025 · Ongoing
- Class II Testosterone / Triamcinolone Acetonide Pellet (200MG/40MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, S… CGMP Deviations: Potential presence of metal particulate matter Farmakeio Outsourcing Llc · Nov 5, 2025 · Ongoing